NICE encourages further data collection on ‘game changing’ histology independent cancer drugs

Larotrectinib (also called Vitrakvi and made by Bayer), a new treatment for a range of cancers, can’t be recommended for use in the NHS because at its current price, it doesn’t have the potential to be cost-effective.

Read news story



NICE Annual Conference 2020

NICE 2020: Connecting evidence, people and practice will showcase the latest developments in clinical improvement, health technologies and patient-centred care. The event will outline the innovations shaping health and care, together with practical advice for those on the frontline of delivering high quality care.

The event takes place on Wednesday 11 November 2020 at the Hilton Manchester Deansgate.

Press and media

Contact the press office: 0300 323 0142 |